Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
1995-06-06
2001-08-07
Mertz, Prema (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S069700, C435S252800, C435S320100, C435S325000, C536S023100, C536S023400, C536S023500
Reexamination Certificate
active
06270998
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to DNAs coding for human cell surface antigen (hereinafter referred to as Fas or Fas antigen) and to vectors for expressing for said DNAs.
BACKGROUND OF THE INVENTION
Fas is a polypeptide that exists in the surfaces of a variety of cells and is considered to be deeply concerned with the apoptosis of cells. The apoptosis is a form of death of cells that is distinguished from the so-called necrosis of cells, and is observed at the time of death of various cells such as of embryogenesis, metamorphosis, endocrine-dependent tissue atrophy and turnover of normal tissues [Wyllie et al. Int. Rev. Cytol. 68, 251-306, 1980; Walker et al. Meth. Achiev. Exp. Pathol. 13, 18-54, 1988; Schmidt et al. Proc. Natl. Acad. Sci. USA 83, 1881-1885, 1986; Ucker et al. Nature 327, 62-64, 1987; Smith et al. Nature 337, 181-184, 1989, Williams et al. Nature 343, 76-79, 1990].
The following features have been pointed out as a result of the morphological and biochemical analyses of cells at the apoptosis:
The apoptosis is accompanied by condensation of cytoplasm, loss of plasma membrane microvilli, segmentation of the nucleus, extensive degradation of chromosomal DNA (into oligomers of about 180 base pair units), and formation of apoptotic bleb [Wyllie et al. 1980 (mentioned above)]. The apoptosis is a physiologically and medically interesting phenomenon because it is a form associated with the death of immunocytes such as thymocytes and the extinction of the tumor cells.
In regression of tumor (alleviation of tumor), in general, the apoptosis mediates the death of target cells by interaction with natural killer cells or cytotoxic T lymphocytes [Duke et al. Proc. Natil. Acad. Sci. USA 80, 6361-6365, 1983; Schmidt et al, 1986 ibid.; Ucker, 1987 (mentioned above)], or by tumor necrosis factor-&agr; (TNF-&agr;) or its related cytokine lymphotoxin (TNF-&bgr;) against the target cells [Schmidt et al, 1986 (mentioned above); Dealtry et al. Eur. J. Immunol. 17, 689-693, 1987; Larrick and Wright, FASEB J. 4, 3215-3223, 1990].
With regard to the relationship between the Fas antigen and the apoptosis, the present inventors have previously disclosed that the mouse monoclonal antibody against the human Fas antigen has a cytolytic activity on human cells expressing the Fas antigen while it does not act upon mouse cells [Yonehara et al. J. Exp. Med. 169, 1747-1756, 1989]. It has also been disclosed by Trauth et al. that the anti-Apo-I antibody has effects analogous to those of the anti-Fas antibody [Science 245, 301-305, 1989].
In a recent study by the present inventors, furthermore, it has been found that cells infected with human immunodeficiecy virus (HIV) are more sensitive to the cytocidal activity of the anti-Fas monoclonal antibody than uninfected cells [Kobayashi et al. Proc. Natl. Acad. Sci. USA 87, 9620-9624, 1990]. However, it is still not clear whether the expression of the Fas antigen that is predominant in the infected cells is actually induced by infection with HIV or by a general transformation.
It is also considered potential to specifically drive the HIV- infected cells into apoptosis by using a monoclonal antibody specific to Fas antigen.
The present inventors have further discovered that the. treatment of human colon carcinoma HT-29 cells with interferon-&ggr; (INF-&ggr;) induces the Fas antigen on the cell surface, and renders the tumor cells more susceptible to the cytotoxic activity of the anti-Fas antibody (Yonehara et al, J. Exp. Med., 169: 1747-1756, 1989).
As described above, it has been pointed out that the Fas antigen is closely related to the apoptosis but numerous points remain not clarified. Therefore, it is physiologically and pathologically meaningful to disclose the entire structure of the Fas antigen and to clarify its function. It is further considered that various monoclonal antibodies that specifically reacts with Fas may be easily obtained if the structure of the Fas antigen is disclosed, and used in treating diseases associated with HIV infection and malignant tumors to be cured.
Therefore, it is physiologically and pathologically very advantageous to clarify the main body of Fas antigen, to clarify its complete structure and to clarify its function. Furthermore, if the Fas antigen is obtained in large amounts in pure form, it will become possible to more clearly analyze its structure and functions. By utilizing the knowledge related to the thus clarified structure of Fas antigen, it will still become possible to study the Fas antigen analogs by modifying them as well as to utilize in large amounts only those portions essential to the expression of the functions.
With the structure of the Fas antigen being clarified, furthermore, it will become possible to obtain various monoclonal antibodies that specifically reacts with Fas as well as to obtain various ligands, agonists and antagonists related to Pas, and to develop studies with regard to their effects upon the cells and relationships of the structure and activities thereof.
In order to accomplish the above object, it is essential to establish means capable of supplying Fas polypeptides in sufficient amounts. In recent years, a recombinant DNA technology has been utilized as a method for preparing physiologically active substance. In order to prepare the Fas antigen by utilizing the above technology, however, it is necessary to isolate DNA that encodes Fas proteins followed by cloning.
SUMMARY OF THE INVENTION
The present inventors have succeeded in the development of means capable of producing in large amounts the human Fas antigen in pure form. The present inventors have clarified the genes of the human Fas antigen and have disclosed, for the first time, how to genetically manipulate the Fas antigen genes.
The present invention provides DNA coding for human Fas antigens, DNA derived therefrom, and DNA fragments thereof. They may include those having an anti-sense sequence thereof. The present invention further provides products such as proteins and peptides produced by using the DNA that encodes the Fas antigen or by using derivatives thereof.
The invention also provides plasmids or vectors that carry DNA coding for the Fas antigen or DNA derived therefrom or fragments thereof. Moreover, the invention provides a variety of transformants that hold replicably or expressibly the plasmid or the vector therein. The present invention encompasses a variety of products produced by utilizing base sequence information of DNA encoding the Fas antigen.
REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: WO9606111A1 (1996-02-01), None
patent: WO9641865A1 (1996-12-01), None
American Type Culture Collection (ATCC) Catalogue of Cell Lines and Hybridomas, Fifth Edition, 1985, pp. 245-246.
Bowie, J.U. et al. Science 247:1306-1310, Mar. 1990.*
Kumar, V. et al. PNAS 87:1337-1341, Feb. 1990.*
Smith, G.A. et al. Science 248:1019-1023, May 1990.*
Itoh, N. et al. Cell 66:233-243, Jul. 1991.*
Trauth, B.C. et al. Science 245:301-305, Jul. 1989.*
Cryz, S.J. (ed.) “Vaccines and Immunotherapy”, published by Pergamon Press (N.Y.), see Chapter 17, pp. 211-223, 1991.
Itoh Naoto
Nagata Shigekazu
Yonehara Shin
Birch Stewart Kolasch & Birch, LLP.
Gucker Stephen
Mertz Prema
Osaka Bioscience Institute
LandOfFree
DNA coding for human cell surface antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA coding for human cell surface antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA coding for human cell surface antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2491378